Erica Mc Laughlin Cabot Corp (CBT) insider trading activity

Erica Mc Laughlin is Executive Vice President, CFO of CABOT CORP. Currently has a direct ownership of 67,068 shares of CBT, which is worth approximately $6.15 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 4,197 shares (Common Stock) at a price of $108.82 per share, resulting in proceeds of $456,717. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.1K

12.13% 3M change

12.13% 12M change

Total Value Held $6.15 Million

Erica McLaughlin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Payment of exercise price or tax liability	$456,717 $108.82 p/Share	4,197 Reduced 5.89%	67,068 Common Stock
Nov 18 2024	BUY Grant, award, or other acquisition	-	10,090 Added 12.4%	71,265 Common Stock
Nov 12 2024	SELL Payment of exercise price or tax liability	$287,202 $112.54 p/Share	2,552 Reduced 4.0%	61,175 Common Stock
Nov 08 2024	BUY Grant, award, or other acquisition	-	3,913 Added 5.79%	63,727 Common Stock
Aug 27 2024	SELL Open market or private sale	$1,709,640 $104.31 p/Share	16,390 Reduced 21.51%	59,814 Common Stock
Aug 27 2024	BUY Exercise of conversion of derivative security	$821,466 $50.12 p/Share	16,390 Added 18.64%	71,528 Common Stock
Aug 08 2024	SELL Open market or private sale	$1,086,700 $98.06 p/Share	11,082 Reduced 15.63%	59,814 Common Stock
Aug 08 2024	BUY Exercise of conversion of derivative security	$555,429 $50.12 p/Share	11,082 Added 14.99%	62,827 Common Stock
Aug 07 2024	SELL Open market or private sale	$2,352,535 $101.08 p/Share	23,274 Reduced 28.01%	59,814 Common Stock
Aug 07 2024	BUY Exercise of conversion of derivative security	$1,166,492 $50.12 p/Share	23,274 Added 24.4%	72,123 Common Stock
Dec 14 2023	SELL Open market or private sale	$2,968,981 $82.2 p/Share	36,119 Reduced 37.65%	59,814 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$1,479,795 $40.97 p/Share	36,119 Added 27.35%	95,933 Common Stock
Nov 20 2023	SELL Payment of exercise price or tax liability	$643,449 $77.89 p/Share	8,261 Reduced 12.14%	59,814 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	7,969 Added 10.48%	68,075 Common Stock
Nov 13 2023	SELL Payment of exercise price or tax liability	$243,797 $74.08 p/Share	3,291 Reduced 5.19%	60,106 Common Stock
Nov 10 2023	BUY Grant, award, or other acquisition	-	5,443 Added 7.91%	63,397 Common Stock
Nov 21 2022	SELL Payment of exercise price or tax liability	$224,255 $71.51 p/Share	3,136 Reduced 5.13%	57,954 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	-	13,462 Added 18.06%	61,090 Common Stock
Nov 11 2022	BUY Grant, award, or other acquisition	-	5,078 Added 9.63%	47,628 Common Stock
Nov 08 2022	SELL Payment of exercise price or tax liability	$153,173 $70.07 p/Share	2,186 Reduced 4.89%	42,550 Common Stock
May 31 2022	SELL Open market or private sale	$702,394 $77.0 p/Share	9,122 Reduced 16.94%	44,736 Common Stock
May 31 2022	BUY Exercise of conversion of derivative security	$413,591 $45.34 p/Share	9,122 Added 14.48%	53,858 Common Stock
Nov 22 2021	SELL Payment of exercise price or tax liability	$63,201 $59.68 p/Share	1,059 Reduced 2.31%	44,736 Common Stock
Nov 22 2021	BUY Grant, award, or other acquisition	-	11,164 Added 19.6%	45,795 Common Stock
Nov 12 2021	BUY Grant, award, or other acquisition	-	5,277 Added 13.22%	34,631 Common Stock

Also insider at

AZTA

Azenta, Inc. Healthcare